Daiichi Sankyo develops, makes, and sells prescription medicines and healthcare products. Its main offerings include cancer treatments, cardiovascular medicines, and vaccines for hospitals, clinics, and patients worldwide.
Daiichi Sankyo products and services overview:
Revenue: ~$13 billion
Employees: 19,000
Headquarters: Tokyo, Japan
Daiichi Sankyo is one of the...
Daiichi Sankyo is a company listed under the stock ticker 4568 (JP).
Daiichi Sankyo has a direct presence in 10 countries.Daiichi Sankyo has 11 subsidiaries including American Regent, ASCA and Daiichi Sankyo Benelux.
They are in:
View the org chart displaying its 116 main executives
Create your alert
to follow the executive moves at Daiichi Sankyo.
Daiichi Sankyo has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.